WELCHOL TABLETS (COLESEVELAM HCL)

Serial Number 77135420
Registration 3454817
800

Registration Progress

Application Filed
Mar 20, 2007
Under Examination
Nov 13, 2007
Approved for Publication
Aug 1, 2007
Published for Opposition
Aug 21, 2007
Registered
Jun 24, 2008

Trademark Image

WELCHOL TABLETS (COLESEVELAM HCL)

Basic Information

Serial Number
77135420
Registration Number
3454817
Filing Date
March 20, 2007
Registration Date
June 24, 2008
Published for Opposition
August 21, 2007
Renewal Date
June 24, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 12, 2018
Registration
Registered
Classes
005

Rights Holder

COSETTE PHARMACEUTICALS, INC.

03
Address
200 CROSSING BLVD.
BRIDGEWATER, NJ 08807

Ownership History

Daiichi Sankyo, Inc.

Original Applicant
03
Parsippany, NJ

Daiichi Sankyo, Inc.

Owner at Publication
03
Parsippany, NJ

Daiichi Sankyo, Inc.

Original Registrant
03
Parsippany, NJ

COSETTE PHARMACEUTICALS, INC.

New Owner After Registration #1
03
BRIDGEWATER, NJ

Legal Representation

Attorney
Mark A. Mazza

USPTO Deadlines

Next Deadline
1067 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-06-24)
Due Date
June 24, 2028
Grace Period Ends
December 24, 2028

Application History

39 events
Date Code Type Description Documents
Oct 16, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 25, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 25, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 25, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 23, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 18, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 18, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 18, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 12, 2018 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Apr 12, 2018 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Apr 12, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 12, 2018 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Mar 29, 2018 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jun 24, 2017 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Dec 11, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 21, 2014 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 21, 2014 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 21, 2014 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 6, 2014 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jun 24, 2008 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 21, 2008 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
May 20, 2008 ALIE A ASSIGNED TO LIE Loading...
May 19, 2008 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 16, 2008 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 5, 2008 IUAF S USE AMENDMENT FILED Loading...
May 5, 2008 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 13, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 21, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 1, 2007 NPUB O NOTICE OF PUBLICATION Loading...
Jul 13, 2007 PBIR Z WITHDRAWN FROM PUB - TQR/NON-ATTY REQUEST Loading...
Jul 12, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 12, 2007 ALIE A ASSIGNED TO LIE Loading...
Jun 8, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 7, 2007 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 7, 2007 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 7, 2007 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 25, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2007 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Mar 23, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the reduction of elevated cholesterol in patients having primary hypercholesterolemia; pharmaceutical preparations for the treatment of diabetes
First Use Anywhere: Jan 18, 2008
First Use in Commerce: Jan 18, 2008

Additional Information

Design Mark
The mark consists of two arrows which appear to left of the word "WELCHOL". The larger, outer arrow appears in the colors blue and green and the arrow connects to the right-hand portion of the letter "W" in the word "WELCHOL". The smaller, inner arrow appears in the colors yellow and green and the arrow connects to the left-hand portion of the letter W in "WELCHOL". Both arrows converge to the left of the word "WELCHOL", sharing the same green arrowhead. The words "WELCHOL" and "TABLETS" appear in the color green. The letter "W" in "WELCHOL" is capitalized. The words "COLESEVELAM HCL", enclosed in parenthesis, appear in small, dark gray letters, immediately beneath the "LCHOL" portion of the word "WELCHOL". The parenthesis are also dark gray. The word "TABLETS" appears in small, capital letters immediately above the letter "O" in "WELCHOL", wedged between the letters "H" and "L".
Color Claim
The color(s) blue, green, yellow and gray is/are claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TABLETS" AND "COLESEVELAM HCL"